Package Leaflet: Information for the Patient
Dapagliflozin/Metformin Tecnigen 5 mg/1000 mg film-coated tablets EFG
dapagliflozin/metformin hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
This medicine contains two different active substances called dapagliflozin and metformin. Both belong to a group of medicines called oral antidiabetics. These are medicines that you take by mouth to treat diabetes.
Dapagliflozin/Metformin Tecnigen is used to treat a type of diabetes called “type 2 diabetes” in adult patients (aged 18 years or older) and that normally appears when you are older. If you have type 2 diabetes, your pancreas does not produce enough insulin or your body is not able to use the insulin it produces properly. This leads to a high level of sugar (glucose) in your blood.
To treat diabetes:
It is essential that you continue to follow the dietary and exercise recommendations provided by your doctor, pharmacist, or nurse.
Do not take Dapagliflozin/Metformina Tecnigen
Do not take this medicine if any of the above situations apply to you.
Warnings and precautions
Risk of lactic acidosis
Dapagliflozin/Metformin may cause a very rare but very serious side effect called lactic acidosis, especially if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, severe infections, prolonged fasting or alcohol consumption, dehydration (see more information below), liver problems, and any medical condition in which a part of the body has a reduced oxygen supply (such as acute and severe heart disease).
If any of the above applies to you, consult your doctor for further instructions.
Stop taking Dapagliflozina/Metformina Tecnigen for a short period if you have a disorder that may be associated with dehydration(significant loss of body fluids), such as severe vomiting, diarrhea, fever, heat exposure, or if you drink less fluid than usual. Consult your doctor for further instructions.
Stop taking Dapagliflozina/Metformina Tecnigen and contact a doctor or the nearest hospital immediately if you experience any of the symptoms that produce lactic acidosis,as this condition can lead to a coma.
The symptoms of lactic acidosis include:
Lactic acidosis is a medical emergency and should be treated in a hospital.
Consult your doctor, pharmacist, or nurse before starting to take Dapagliflozina/Metformina Tecnigen, and during treatment:
If you need to undergo major surgery, you should stop taking Dapagliflozina/Metformina while the procedure is being performed and for a period after it. Your doctor will decide when you should stop treatment with Dapagliflozina/Metformina and when to restart it.
It is essential that you regularly check your feet and follow any other foot care advice provided by your healthcare professional.
If any of the above situations apply to you (or you are not sure), talk to your doctor, pharmacist, or nurse before taking this medicine.
Consult your doctor immediately if you have a combination of symptoms of pain, pain on palpation, redness, or inflammation of the genitals or the area between the genitals and the anus, with fever or general discomfort. These symptoms could be a sign of a rare but serious, potentially life-threatening infection called necrotizing fasciitis of the perineum or Fournier's gangrene, which destroys tissue under the skin. Fournier's gangrene should be treated immediately.
Kidney function
During treatment with Dapagliflozina/Metformina, your doctor will check your kidney function at least once a year or more frequently if you are an older person and/or if your kidney function is worsening.
Glucose in urine
Due to how this medicine works, your urine will test positive for glucose while you are taking this medicine.
Children and adolescents
This medicine is not recommended for children and adolescents under 18 years of age, as it has not been studied in these patients.
Other medicines and Dapagliflozina/Metformina Tecnigen
If you need to be given an injection of a contrast medium that contains iodine into your bloodstream, for example, in the context of an X-ray or scan, you should stop taking Dapagliflozina/Metformina before the injection or at the time of the injection. Your doctor will decide when you should stop treatment with Dapagliflozina/Metformina and when to restart it.
Tell your doctor if you are taking, have recently taken, or might take any other medicines. You may need more frequent blood glucose and kidney function tests, or your doctor may need to adjust the dose of Dapagliflozina/Metformina. It is especially important to mention the following:
Taking Dapagliflozina/Metformina Tecnigen with alcohol
Avoid excessive alcohol consumption while taking Dapagliflozina/Metformina, as this can increase the risk of lactic acidosis (see section “Warnings and precautions”).
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. You should stop taking this medicine if you become pregnant, as it is not recommended during the second and third trimesters of pregnancy (the last six months). Consult your doctor about the best way to control your blood sugar during pregnancy.
Consult your doctor if you want to breastfeed or are breastfeeding before taking this medicine. You should not use this medicine during breastfeeding. Metformin passes into breast milk in small amounts. It is not known if dapagliflozin passes into breast milk.
Driving and using machines
This medicine has a negligible influence on the ability to drive and use machines. Taking it with other medicines that lower the amount of sugar in the blood, such as insulin or a “sulfonylurea” type medicine, can cause very low blood sugar levels (hypoglycemia), which can cause symptoms such as weakness, dizziness, increased sweating, rapid heartbeat, vision changes, or difficulty concentrating, which can affect your ability to drive or use machines. Do not drive or use tools or machines if you start to feel these symptoms.
Sodium content
This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
How much to take
How to take this medicine
Your doctor may prescribe this medicine along with other medicine(s) to lower the amount of sugar in your blood. These may be oral medicine(s) and/or injectable medicine(s), such as insulin or a GLP-1 receptor agonist. Remember to take these other medicines following your doctor's instructions. This will help you get the best results for your health.
Diet and exercise
To control your diabetes, you should continue with diet and exercise, even when taking this medicine. Therefore, it is essential that you continue to follow the dietary and exercise recommendations provided by your doctor, pharmacist, or nurse. In particular, if you are following a weight control diet for diabetics, continue with it while taking this medicine.
If you take more Dapagliflozina/Metformina Tecnigen than you should
If you take more tablets of Dapagliflozina/Metformina than you should, you may experience lactic acidosis. The symptoms of lactic acidosis include having a lot of nausea or vomiting, stomach pain, muscle cramps, intense fatigue, or difficulty breathing. If this happens to you, you may need immediate hospital treatment, as lactic acidosis can lead to a coma. Stop taking this medicine immediately and contact a doctor or the nearest hospital right away (see section 2). Bring the medicine pack with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Dapagliflozina/Metformina Tecnigen
If you forget a dose, take it as soon as you remember. If you do not remember until it is time for your next dose, skip the missed dose and follow your regular schedule. Do not take a double dose of this medicine to make up for missed doses.
If you stop taking Dapagliflozina/Metformina Tecnigen
Do not stop taking this medicine without first talking to your doctor. Your blood sugar may increase without this medicine.
If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Stop taking Dapagliflozina/Metformina Tecnigen and consult a doctor immediately if you notice any of these serious or potentially serious adverse effects:
Dapagliflozina/Metformina may cause a very rare but very serious adverse effect called lactic acidosis (see section "Warnings and Precautions"), If this happens to you, you must stop takingDapagliflozina/Metforminaand contact a doctor or the nearest hospital immediately, as lactic acidosis can lead to coma.
Contact a doctor or the nearest hospital immediately if you experience any of the following adverse effects:
These are the signs of diabetic ketoacidosis (see also section 2 Warnings and Precautions):
This can occur despite blood glucose levels. Your doctor should decide whether to temporarily or permanently interrupt your treatment with Dapagliflozina/Metformina.
Stop taking Dapagliflozina/Metformina Tecnigen and consult a doctor as soon as possible if you notice any of the following serious or potentially serious adverse effects:
These are the signs of a serious urinary tract infection:
Although it is infrequent, if you notice blood in your urine, inform your doctor immediately.
Contact a doctor as soon as possible if you experience any of the following adverse effects:
The signs of low blood sugar are:
Your doctor will explain how to treat low blood sugar and what to do if you experience any of the above signs. If you have symptoms of low blood sugar, take glucose tablets, a sugary snack, or drink a fruit juice. Measure your blood sugar level, if possible, and rest.
Other adverse effects include:
Very frequent
Frequent
Uncommon(may affect up to 1 in 100 people)
Very rare
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister or packaging after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition ofDapagliflozina/Metformina Tecnigen
Each film-coated tablet (tablet) contains dapagliflozina propanediol monohydrate equivalent to 5 mg of dapagliflozina and 1000 mg of metformina hydrochloride.
Appearance of the Product and Package Contents
They are available in PCTFE/PVC/Alu blisters with 56 tablets.
Marketing Authorization Holder
Tecnimede España Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas (Madrid) Spain
Manufacturer
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua De Tapada Grande 2
Abrunheira, 2710-228 Sintra
Portugal
Date of the Last Revision of this Prospectus: October 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)